Patents by Inventor Dawei Huang

Dawei Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12551500
    Abstract: The present disclosure provides a C6?-substituted locked nucleic acid-modified cap analog and a use thereof, wherein the cap analog improves the stability of mRNA and/or the translation efficiency of mRNA.
    Type: Grant
    Filed: January 3, 2025
    Date of Patent: February 17, 2026
    Assignee: Hangzhou Tianlong Pharmaceutical Co., Ltd.
    Inventors: Gengshen Song, Honglei Zhang, Yangjian Liu, Kai Dong, Jinyu Zhang, Chuan Gao, Lijie Jin, Yuqing Li, Huajie Huang, Yanfen Li, Limin Liang, Xiaowen Yu, Dawei Huang
  • Patent number: 12545637
    Abstract: Provided in the present disclosure is a compound of formula (I), or an N-oxide, solvate, pharmaceutically acceptable salt or stereoisomer thereof, which is an extrahepatic targeted cationic lipid compound with high efficiency and low toxicity. Further provided are a composition containing the aforementioned compound, and the use thereof in the delivery of a therapeutic or prophylactic agent.
    Type: Grant
    Filed: April 10, 2023
    Date of Patent: February 10, 2026
    Assignee: BEIJING YOUCARE KECHUANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
    Inventors: Gengshen Song, Honglei Zhang, Xichao Chen, Huanyu Wang, Dawei Huang, Xiaowen Yu, Yangjian Liu, Yuqing Li, Rucan Yan, Lianyong Qiao, Xiaojuan Li, Xiaoling Chen, Zhenlong Sun, Shuai Wang, Kai Dong, Jinyu Zhang
  • Publication number: 20260009035
    Abstract: Provided are a GalNAc compound containing a ribose ring or its derivative structure and an oligonucleotide conjugate thereof. The oligonucleotide conjugate can achieve efficient liver-targeted delivery and improve the efficacy of the drug.
    Type: Application
    Filed: December 1, 2023
    Publication date: January 8, 2026
    Inventors: Gengshen SONG, Zeao HUANG, Zhenmin LI, Zhikang TIAN, Shuo YANG, Peng YAO, Zhongcai GAO, Xiaowen YU, Dawei HUANG, Xue PANG, Yuhua HOU, Jie WANG, Fang LIN, Yanan CHANG
  • Publication number: 20260007613
    Abstract: Provided in the present invention are long-acting low-toxicity novel cationic lipid compounds, which are compounds shown as formula (I), or N-oxides, solvates, pharmaceutically acceptable salts or stereoisomers thereof. Further provided are a composition comprising the compounds and the use thereof for the delivery of therapeutic or prophylactic agents.
    Type: Application
    Filed: January 19, 2023
    Publication date: January 8, 2026
    Inventors: Gengshen SONG, Honglei ZHANG, Xichao CHEN, Huanyu WANG, Dawei HUANG, Xiaowen YU, Chuan GAO, Xiaobing LV, Jingtang LIAN, Xinlong JIANG, Boyang LI, Xinggai PENG, Yue LI, Yu HAO, Jinyu ZHANG
  • Publication number: 20260008746
    Abstract: The present invention provides a cationic lipid compound with high efficiency, low toxicity and stable expression, which is a compound of formula (I) or an N-oxide, a solvate, a pharmaceutically acceptable salt or a stereoisomer thereof Further provided are a composition comprising the described compound and a use thereof in delivering a therapeutic or prophylactic agent.
    Type: Application
    Filed: January 19, 2023
    Publication date: January 8, 2026
    Inventors: Gengshen SONG, Honglei ZHANG, Huanyu WANG, Xichao CHEN, Dawei HUANG, Xiaowen YU
  • Publication number: 20260007601
    Abstract: A compound of Formula (I) or an N-oxide, a solvate, a pharmaceutically acceptable salt or a stereoisomer thereof is an ionizable cationic lipid compound.
    Type: Application
    Filed: January 19, 2023
    Publication date: January 8, 2026
    Applicant: BEIJING YOUCAREKECHUANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
    Inventors: Gengshen Song, Xichao Chen, Honglei Zhang, Huanyu Wang, Dawei Huang, Xiaowen Yu, Lijie Jin, Yuqing Ma, Ran An, Jing Li, Shuai Wang, Zhenlong Sun, jinyu Zhang
  • Publication number: 20260002160
    Abstract: The present disclosure relates to siRNAs that target and regulate PCSK9 gene expression and use thereof. Experimental results show that some alternately modified and specific template-modified oligonucleotide sequences can significantly inhibit PCSK9 expression and can be used to develop drugs to treat PCSK9-related diseases.
    Type: Application
    Filed: March 18, 2024
    Publication date: January 1, 2026
    Inventors: Gengshen SONG, Zeao HUANG, Shuo YANG, Zhikang TIAN, Yucheng WU, Peng YAO, Xiaowen YU, Dawei HUANG, Xue PANG, Fang LIN
  • Publication number: 20250348489
    Abstract: Latency, response times, and efficiency improvements for data querying are provided herein, particularly in the context of querying large database systems and data tables from disparate data sources. There are provided systems and methods for automatic query and data retrieval optimization through procedural generation of data tables from query patterns. A service provider may utilize different computing services for query processing and data retrieval for different applications and services used by internal and/or external users. Instead of querying large database systems and numerous data tables, pre-aggregated data tables may instead be used and searched by procedurally generating such tables based on precomputation rules and query patterns. Once patterns have been identified in queries, corresponding data may be aggregated from data sources in a pre-aggregated data table. Query optimization rules may then be used to have these data tables queried in place of their original sources.
    Type: Application
    Filed: June 16, 2025
    Publication date: November 13, 2025
    Inventors: Chongchen Chen, Si Feng, Dawei Huang
  • Patent number: 12361000
    Abstract: Latency, response times, and efficiency improvements for data querying are provided herein, particularly in the context of querying large database systems and data tables from disparate data sources. There are provided systems and methods for automatic query and data retrieval optimization through procedural generation of data tables from query patterns. A service provider may utilize different computing services for query processing and data retrieval for different applications and services used by internal and/or external users. Instead of querying large database systems and numerous data tables, pre-aggregated data tables may instead be used and searched by procedurally generating such tables based on precomputation rules and query patterns. Once patterns have been identified in queries, corresponding data may be aggregated from data sources in a pre-aggregated data table. Query optimization rules may then be used to have these data tables queried in place of their original sources.
    Type: Grant
    Filed: March 19, 2024
    Date of Patent: July 15, 2025
    Assignee: PAYPAL, INC.
    Inventors: Chongchen Chen, Si Feng, Dawei Huang
  • Publication number: 20250222019
    Abstract: The present disclosure provides a C6?-substituted locked nucleic acid-modified cap analog and a use thereof, wherein the cap analog improves the stability of mRNA and/or the translation efficiency of mRNA.
    Type: Application
    Filed: January 3, 2025
    Publication date: July 10, 2025
    Inventors: Gengshen Song, Honglei Zhang, Yangjian Liu, Kai Dong, Jinyu Zhang, Chuan Gao, Lijie Jin, Yuqing Li, Huajie Huang, Yanfen Li, Limin Liang, Xiaowen Yu, Dawei Huang
  • Publication number: 20250199985
    Abstract: A reconfigurable dataflow unit (RDU) includes an intra-RDU network, an array of configurable units connected by an array level network and function interfaces. The RDU also includes interface circuits coupled between the intra-RDU network and external interconnects. An interface circuit receives a packet from the external interconnect and extracts a target RDU identifier and compares the target RDU identifier to the value of the identity register. It also communicates over the intra-RDU network to a function interface based on information in the first packet in response to the target RDU identifier being equal to the identity register. The interface circuit retrieves another interface circuit identifier for the target RDU identifier from the pass-through table and, in response to the target RDU identifier not being equal to the identity register, sends the target RDU identifier and other information to the other interface circuit over the intra-RDU network.
    Type: Application
    Filed: February 25, 2025
    Publication date: June 19, 2025
    Applicant: SambaNova Systems, Inc.
    Inventors: Paul JORDAN, Manish K. SHAH, Emre Ali BURHAN, Dawei HUANG, Yong QIN
  • Patent number: 12271333
    Abstract: A reconfigurable dataflow unit (RDU) includes an intra-RDU network, an array of configurable units connected by an array level network and function interfaces. The RDU also includes interface circuits coupled between the intra-RDU network and external interconnects. An interface circuit receives a packet from the external interconnect and extracts a target RDU identifier and compares the target RDU identifier to the value of the identity register. It also communicates over the intra-RDU network to a function interface based on information in the first packet in response to the target RDU identifier being equal to the identity register. The interface circuit retrieves another interface circuit identifier for the target RDU identifier from the pass-through table and, in response to the target RDU identifier not being equal to the identity register, sends the target RDU identifier and other information to the other interface circuit over the intra-RDU network.
    Type: Grant
    Filed: July 5, 2023
    Date of Patent: April 8, 2025
    Assignee: SambaNova Systems, Inc.
    Inventors: Paul Jordan, Manish K. Shah, Emre Ali Burhan, Dawei Huang, Yong Qin
  • Publication number: 20250109092
    Abstract: Provided in the present disclosure is a compound of formula (I), or an N-oxide, solvate, pharmaceutically acceptable salt or stereoisomer thereof, which is an extrahepatic targeted cationic lipid compound with high efficiency and low toxicity. Further provided are a composition containing the aforementioned compound, and the use thereof in the delivery of a therapeutic or prophylactic agent.
    Type: Application
    Filed: April 10, 2023
    Publication date: April 3, 2025
    Inventors: Gengshen SONG, Honglei ZHANG, Xichao CHEN, Huanyu WANG, Dawei HUANG, Xiaowen YU, Yangjian LIU, Yuqing LI, Rucan YAN, Lianyong QIAO, Xiaojuan LI, Xiaoling CHEN, Zhenlong SUN, Shuai WANG, Kai DONG, Jinyu ZHANG
  • Publication number: 20250082576
    Abstract: Provided in the present disclosure are a compound of formula (I), or an N-oxide, solvate, pharmaceutically acceptable salt or stereoisomer thereof. Further provided are a composition containing the aforementioned compound, and the use thereof in the delivery of a therapeutic agent or prophylactic agent.
    Type: Application
    Filed: November 22, 2024
    Publication date: March 13, 2025
    Inventors: Gengshen Song, Huanyu Wang, Honglei Zhang, Xichao Chen, Xiaowen Yu, Dawei Huang
  • Patent number: 12171876
    Abstract: Provided in the present disclosure are a compound of formula (I), or an N-oxide, solvate, pharmaceutically acceptable salt or stereoisomer thereof. Further provided are a composition containing the aforementioned compound, and the use thereof in the delivery of a therapeutic agent or prophylactic agent.
    Type: Grant
    Filed: January 27, 2022
    Date of Patent: December 24, 2024
    Assignee: HANGZHOU TIANLONG PHARMACEUTICAL CO., LTD.
    Inventors: Gengshen Song, Huanyu Wang, Hognlei Zhang, Xichao Chen, Xiaowen Yu, Dawei Huang
  • Publication number: 20240252435
    Abstract: Provided in the present disclosure are a compound of formula (I), or an N-oxide, solvate, pharmaceutically acceptable salt or stereoisomer thereof. Further provided are a composition containing the aforementioned compound, and the use thereof in the delivery of a therapeutic agent or prophylactic agent.
    Type: Application
    Filed: January 27, 2022
    Publication date: August 1, 2024
    Inventors: Gengshen Song, Huanyu Wang, Hognlei Zhang, Xichao Chen, Xiaowen Yu, Dawei Huang
  • Patent number: 11886930
    Abstract: The technology disclosed relates to runtime execution of functions across reconfigurable processor. In particular, the technology disclosed relates to a runtime logic that is configured to execute a first set of functions in a plurality of functions and/or data therefor on a first reconfigurable processor, and a second set of functions in the plurality of functions and/or data therefor on additional reconfigurable processors. Functions in the second set of functions and/or the data therefor are transmitted to the additional reconfigurable processors using one or more of a first reconfigurable processor-to-additional reconfigurable processors buffers, and results of executing the functions and/or the data therefor on the additional reconfigurable processors are transmitted to the first reconfigurable processor using one or more of additional reconfigurable processors-to-first reconfigurable processor buffers.
    Type: Grant
    Filed: November 9, 2021
    Date of Patent: January 30, 2024
    Assignee: SambaNova Systems, Inc.
    Inventors: Ram Sivaramakrishnan, Sumti Jairath, Emre Ali Burhan, Manish K. Shah, Raghu Prabhakar, Ravinder Kumar, Arnav Goel, Ranen Chatterjee, Gregory Frederick Grohoski, Kin Hing Leung, Dawei Huang, Manoj Unnikrishnan, Martin Russell Raumann, Bandish B. Shah
  • Patent number: 11886931
    Abstract: The technology disclosed relates to inter-node execution of configuration files on reconfigurable processors using network interface controller (NIC) buffers. In particular, the technology disclosed relates to a runtime logic that is configured to execute configuration files that define applications and application data for applications using a first reconfigurable processor connected to a first host, and a second reconfigurable processor connected to a second host. The first reconfigurable processor is configured to push input data for the applications in a first plurality of buffers. The first host is configured to cause a first network interface controller (NIC) to stream the input data to a second plurality of buffers from the first plurality of buffers. The second host is configured to cause a second NIC to stream the input data to the second reconfigurable processor from the second plurality of buffers.
    Type: Grant
    Filed: November 9, 2021
    Date of Patent: January 30, 2024
    Assignee: SambaNova Systems, Inc.
    Inventors: Ram Sivaramakrishnan, Sumti Jairath, Emre Ali Burhan, Manish K. Shah, Raghu Prabhakar, Ravinder Kumar, Arnav Goel, Ranen Chatterjee, Gregory Frederick Grohoski, Kin Hing Leung, Dawei Huang, Manoj Unnikrishnan, Martin Russell Raumann, Bandish B. Shah
  • Publication number: 20240020261
    Abstract: A reconfigurable dataflow unit (RDU) includes an intra-RDU network, an array of configurable units connected by an array level network and function interfaces. The RDU also includes interface circuits coupled between the intra-RDU network and external interconnects. An interface circuit receives a packet from the external interconnect and extracts a target RDU identifier and compares the target RDU identifier to the value of the identity register. It also communicates over the intra-RDU network to a function interface based on information in the first packet in response to the target RDU identifier being equal to the identity register. The interface circuit retrieves another interface circuit identifier for the target RDU identifier from the pass-through table and, in response to the target RDU identifier not being equal to the identity register, sends the target RDU identifier and other information to the other interface circuit over the intra-RDU network.
    Type: Application
    Filed: July 5, 2023
    Publication date: January 18, 2024
    Applicant: SambaNova Systems, Inc.
    Inventors: Paul JORDAN, Manish K. SHAH, Emre Ali BURHAN, Dawei HUANG, Yong QIN
  • Patent number: D1061723
    Type: Grant
    Filed: August 26, 2024
    Date of Patent: February 11, 2025
    Inventor: Dawei Huang